Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Oct 14, 2009; 15(38): 4775-4780
Published online Oct 14, 2009. doi: 10.3748/wjg.15.4775
Published online Oct 14, 2009. doi: 10.3748/wjg.15.4775
Table 1 Biopsies that would be avoided by considering a cut-off point of 30 U tTG antibody in each Marsh type and age group (%)
| ≤ 2 yr | 3-14 yr | 15-35 yr | > 35 yr | |
| Marsh 1 | 0 | 0/2 | 0/9 (0) | 0/27 (0) |
| Marsh 2 | 0 | 1/1 (100) | 0/19 (0) | 0/15 (0) |
| Marsh 3a | 9/10 (90) | 22/24 (92) | 29/43 (67) | 41/57 (72) |
| Marsh 3b | 28/28 (100) | 20/21 (95) | 22/24 (92) | 15/20 (75) |
| Marsh 3c | 10/10 (100) | 1/1 (100) | 7/7 (100) | 6/6 (100) |
| No. of biopsies avoided | 47/48 (98) | 44/49 (90) | 58/102 (57) | 62/125 (50) |
- Citation: Vivas S, Ruiz de Morales JG, Riestra S, Arias L, Fuentes D, Alvarez N, Calleja S, Hernando M, Herrero B, Casqueiro J, Rodrigo L. Duodenal biopsy may be avoided when high transglutaminase antibody titers are present. World J Gastroenterol 2009; 15(38): 4775-4780
- URL: https://www.wjgnet.com/1007-9327/full/v15/i38/4775.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.4775